Technical Description
This technology is a novel class of heterocyclic thioacetamide derivatives designed to effectively inhibit SHP2 for therapeutic applications in SHP2-mediated diseases.
Problems Addressed
- Limited Aquaporin 9 Modulation
- Inefficient Hyperglycemia Control
- Restricted Apoptosis Activation
- Low Membrane Depolarization
- Limited Antimicrobial Activity
- Inefficient SHP2 Inhibition
Tech Features
- Efficient SHP2 Inhibition
- Enhanced Binding Mechanism
- Targeted Enzyme Modulation
- Improved Antioxidant Activity
- Optimized Antiproliferative Effects
Target Audience
- Pharmaceutical Industry
- Biotechnology Sector
- Healthcare & Therapeutics Industry
- Academic & Research Institutions
- Life Sciences & Precision Medicine Industry
Tech ID: P27-1402 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
